Helping the Biotech Industry Bring Crucial Healthcare Innovations to Market Todd Applebaum recently talked with Mission Matters about helping the biotech industry bring crucial healthcare innovations to market. Read the interview highlights on the Mission Matters website. Watch the full interview here:
PDF Available > Planning for, establishing, and managing the Clinical Supply Chain has its own set of challenges – regulatory requirements, clinical uncertainties, nuances of sourcing drug substance and API material, and logistical constraints including access to new points of patient care. Clinical supply leaders need to manage all of these while ensuring quality [...]
PDF Available > DSCSA serialization regulations in the U.S. and EUFMD directives in Europe are now being enforced for manufacturers. Other standards around the globe are also advancing. The focus of Life Sciences manufacturers is shifting from serialization planning and preparation to execution, management, and business value. With manufacturer requirements in place, serialization is [...]
Life Sciences Supply Chain Working Group Webinar on 11/16 @ 12-1p ET Building High-Touch Patient Supply Chains Read the Event Recap This event will provide insights on emerging methods and practices for designing supply chains focused on building and maintaining close relationships with physicians and patients. Supply Chain Working Group [...]
Emerging pharmaceutical companies frequently place responsibility for clinical supply chain management on their clinical operations team and CROs. This approach can work initially for small, resource-constrained organizations. However, it does not help companies build the internal capabilities, knowledge, and resources to successfully run their clinical supply chain over time as they grow. One [...]
Converge develops commercial supply chain business processes, commercial systems architecture & last mile strategies. Our client was an emerging pharmaceutical company focused on rare diseases, in clinical trials with an ultra-orphan drug. There were two competitive therapies also in development, so they began preparations for commercial launch on a compressed timeline to [...]
Life Sciences Supply Chain Working Group Webinar on June 29 @ 11a-12p The CARES Act & Your Supply Chain: What You Need to Know Now Read the Event Recap The Coronavirus Aid, Relief, and Economic Security (“CARES”) Act, signed in March 2020, provides emergency assistance and health care response for [...]
After spending years researching, developing, and testing innovative drug candidates, emerging biopharmaceutical companies successfully progressing in clinical development begin preparing for their first commercial launch. As this organizational transformation nears, the focus of the IT organization shifts from infrastructure and help desk support to business enablement as new functions like Sales, Medical Affairs, [...]
Roundtable with 4G Clinical on 6/2/21 Why is Now the Time for Digital Supply Chain Transformation Read the Event Recap Clinical supply professionals are charged with getting the right drug to the right patient at the right time - at the lowest possible cost and resource allocation. While the supply chain itself [...]
As life science companies advance beyond the first launch of commercial products, strategic focus shifts. Attention moves to expanding the business, regulatory and geographic reach of their treatments. Market expansion, label expansion, and further pipeline development create more opportunities. Companies pursue these efforts in parallel as quickly as possible. The initial supply and [...]